- Home
- GOSS vs PSTL Comparison
GOSS vs PSTL Comparison
Compare GOSS & PSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PSTL
- Stock Information
- Founded
- GOSS 2015
- PSTL 2018
- Country
- GOSS United States
- PSTL United States
- Employees
- GOSS N/A
- PSTL N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PSTL Real Estate Investment Trusts
- Sector
- GOSS Health Care
- PSTL Real Estate
- Exchange
- GOSS Nasdaq
- PSTL Nasdaq
- Market Cap
- GOSS 347.8M
- PSTL 329.8M
- IPO Year
- GOSS 2019
- PSTL 2019
- Fundamental
- Price
- GOSS $2.47
- PSTL $15.84
- Analyst Decision
- GOSS Strong Buy
- PSTL Strong Buy
- Analyst Count
- GOSS 4
- PSTL 1
- Target Price
- GOSS $8.50
- PSTL $17.75
- AVG Volume (30 Days)
- GOSS 3.1M
- PSTL 149.9K
- Earning Date
- GOSS 08-05-2025
- PSTL 08-04-2025
- Dividend Yield
- GOSS N/A
- PSTL 6.12%
- EPS Growth
- GOSS N/A
- PSTL 344.13
- EPS
- GOSS N/A
- PSTL 0.39
- Revenue
- GOSS $40,237,000.00
- PSTL $86,535,000.00
- Revenue This Year
- GOSS N/A
- PSTL $22.00
- Revenue Next Year
- GOSS $30.65
- PSTL $9.76
- P/E Ratio
- GOSS N/A
- PSTL $40.92
- Revenue Growth
- GOSS N/A
- PSTL 26.43
- 52 Week Low
- GOSS $0.66
- PSTL $12.26
- 52 Week High
- GOSS $2.65
- PSTL $15.84
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- PSTL 70.89
- Support Level
- GOSS $2.38
- PSTL $15.31
- Resistance Level
- GOSS $2.65
- PSTL $15.55
- Average True Range (ATR)
- GOSS 0.15
- PSTL 0.24
- MACD
- GOSS 0.03
- PSTL 0.11
- Stochastic Oscillator
- GOSS 76.67
- PSTL 100.00
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PSTL Postal Realty Trust Inc.
Postal Realty Trust Inc is an internally managed real estate corporation that owns and manages properties leased to the United States Postal Service, or the USPS. Its objective is to create stockholder value by generating risk-adjusted returns through expanding its portfolio of owned and managed postal properties leased to the USPS. The majority of the revenue is generated from the rental income received.